Latest News
Eisai reports new data showing etalanetug reduces Alzheimer's Disease tau tangle‑specific biomarker
13 July 2026 - Japanese pharmaceutical company Eisai Co., Ltd. (TYO: 4523) on Monday reported new findings showing that its investigational anti-MTBR antibody etalanetug (E2814) reduced levels of plasma eMTBR-tau243, a biomarker linked to tau tangle ...
Takeda and Indonesia launch partnership to expand plasma-derived medicine production
13 July 2026 - Japanese pharmaceutical company Takeda (TSE:4502) (NYSE:TAK) announced on Monday that it has entered into a multi-year collaboration with the Indonesian government to strengthen the country's plasma ecosystem, following the Minist...
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
13 July 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has received marketing authorisation in Sweden for Tofacitinib Newbury 5 mg and 10 mg film-coated tablets, marking the first approval in...
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
13 July 2026 - Evaxion A/S (NASDAQ: EVAX), a Denmark-based clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, on Sunday presented new data further supporting the multi-component concept of its cytomegalovirus (C...
HDT Bio Launches Canadian clinical programme for brain cancer treatment
13 July 2026 - US-based clinical-stage biotechnology company HDT Bio Corp announced on Sunday the establishment of HDT Bio Canada Inc, its Canadian subsidiary, formed to advance its cancer immunotherapy programs through Canadian clinical development,...